Archives for November 9, 2018

NEWS IN BRIEF

WuXi Biologics breaks ground on $240m manufacturing site near Beijing

Construction has started at WuXi Biologics’ eighth drug substance manufacturing facility, which CEO Chris Chen says will enable the CDMO to “develop and manufacture biologics more cost effectively”.

GE Healthcare strengthens single-use manufacturing in China

GE Healthcare will manufacture single-use consumables for bioprocessing through a collaboration with Wego.

Coherus receives US FDA approval for Neulasta biosimilar, pricing 33% lower

The company will launch Udenyca onto the US market on January 3, 2019, to compete with Amgen’s originator product and Mylan’s rival biosimilar.